Overview
Masayuki Haruta practices in Komuro, Japan. Mr. Haruta is rated as a Distinguished expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Neuroblastoma, and Embryonal Tumor with Multilayered Rosettes.
His clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- WT1-Related Wilms Tumor SyndromesMr. Haruta isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- NeuroblastomaMr. Haruta isAdvanced. Learn about Neuroblastoma.
- Wilms TumorMr. Haruta isAdvanced. Learn about Wilms Tumor.
- Experienced
- Aplastic AnemiaMr. Haruta isExperienced. Learn about Aplastic Anemia.
- Bladder CancerMr. Haruta isExperienced. Learn about Bladder Cancer.
- Congenital Aplastic AnemiaMr. Haruta isExperienced. Learn about Congenital Aplastic Anemia.
- Fanconi AnemiaMr. Haruta isExperienced. Learn about Fanconi Anemia.
- Gliomatosis CerebriMr. Haruta isExperienced. Learn about Gliomatosis Cerebri.
- HepatoblastomaMr. Haruta isExperienced. Learn about Hepatoblastoma.